Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience. (2021). Radiology and Oncology, 55(4), 482-490. https://radioloncol.com/index.php/ro/article/view/3757